Insights On Trial Design

1. How To Recruit 236 Patients In An Osteoarthritis Study On Time During The Peak Of The Pandemic 7/23/2024

   A leading Eastern European contract research organization completed the recruitment of 236 subjects in a Phase 3 osteoarthritis study for Handok Inc. despite hurdles caused by the COVID-19 pandemic.

2. Exploring Global Clinical Research Perspectives On RA Insights 2/5/2024

   Explore how the research into Rheumatoid Arthritis, which affects 17.6 million people worldwide, aims to improve treatment effectiveness and future interventions.

3. How PXO Unlocks Enrollment And Equity In Ultra-Orphan Trials 8/5/2025

   Patient Experience Optimization not only enhances operational efficiency but also rebuilds trust with a patient population that is discerning, not desperate.

4. Understanding The Current Global Landscape Of Pancreatic Cancer Clinical Trials 9/17/2024

   Pancreatic cancer, an aggressive gastrointestinal malignancy, presents a significant global health challenge. Delve into the current state of research and discover emerging therapeutic strategies.

5. Boosting Recruitment Strategy For Phase III Study In Ulcerative Colitis 6/10/2025

   Learn about the successful execution of a challenging three-arm, randomized, placebo-controlled Phase 3 study in Ulcerative Colitis despite strict inclusion criteria and a limited patient pool.

6. Delivering Specialist Neurology Support 4/17/2025

   Explore a strategic approach to a Parkinson’s disease trial that leveraged a global infrastructure and multilingual workforce to provide seamless operational and clinical support.

7. A Patient's Life-Changing Experience With Diabetes Research 7/12/2024

   Discover the inspiring journey of one man who battled diabetes and experienced a transformative shift in his life through a patient-focused clinical trial at the Elligo Clinical Research Center.

8. RTSM And Clinical Drug Dispensation 7/16/2024

   A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.

9. 8 Critical Questions To Ask Your IRB 2/5/2025

   This article outlines eight essential questions to ask a potential IRB partner to assess their ability to help you navigate complex regulatory requirements while avoiding delays.

10. 5 Essential Steps To Implementing Decentralized Clinical Trials Globally 9/15/2025

    Running a global decentralized clinical trial requires a strategy that balances the FDA's focus on technology accessibility with the EMA's emphasis on validation and comprehensive documentation.